- Home
- SONN vs BDRX Comparison
SONN vs BDRX Comparison
Compare SONN & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SONN
- BDRX
- Stock Information
- Founded
- SONN N/A
- BDRX 2000
- Country
- SONN United States
- BDRX United Kingdom
- Employees
- SONN N/A
- BDRX N/A
- Industry
- SONN Biotechnology: Pharmaceutical Preparations
- BDRX Biotechnology: Pharmaceutical Preparations
- Sector
- SONN Health Care
- BDRX Health Care
- Exchange
- SONN Nasdaq
- BDRX Nasdaq
- Market Cap
- SONN 2.5M
- BDRX 2.4M
- IPO Year
- SONN N/A
- BDRX N/A
- Fundamental
- Price
- SONN $1.40
- BDRX $1.96
- Analyst Decision
- SONN Strong Buy
- BDRX
- Analyst Count
- SONN 2
- BDRX 0
- Target Price
- SONN $38.00
- BDRX N/A
- AVG Volume (30 Days)
- SONN 70.3K
- BDRX 1.5M
- Earning Date
- SONN 02-13-2025
- BDRX 04-21-2025
- Dividend Yield
- SONN N/A
- BDRX N/A
- EPS Growth
- SONN N/A
- BDRX N/A
- EPS
- SONN N/A
- BDRX N/A
- Revenue
- SONN $1,000,000.00
- BDRX $104,895.00
- Revenue This Year
- SONN N/A
- BDRX N/A
- Revenue Next Year
- SONN N/A
- BDRX N/A
- P/E Ratio
- SONN N/A
- BDRX N/A
- Revenue Growth
- SONN 674.14
- BDRX N/A
- 52 Week Low
- SONN $1.30
- BDRX $1.90
- 52 Week High
- SONN $18.72
- BDRX $74.00
- Technical
- Relative Strength Index (RSI)
- SONN 37.25
- BDRX 23.07
- Support Level
- SONN $1.30
- BDRX $2.78
- Resistance Level
- SONN $1.52
- BDRX $4.44
- Average True Range (ATR)
- SONN 0.10
- BDRX 0.44
- MACD
- SONN -0.00
- BDRX -0.13
- Stochastic Oscillator
- SONN 33.33
- BDRX 2.36
About SONN Sonnet BioTherapeutics Holdings Inc.
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.
About BDRX Biodexa Pharmaceuticals plc American Depositary Shs
Biodexa Pharmaceuticals PLC is a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines. The company combines approved and developed medications with its proprietary and drug delivery technologies to provide compelling products that have the potential to powerfully impact the lives of patients.